Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

China remains an attractive market despite global economic uncertainties, a top executive participating in the ongoing ...

BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 ...

These factors can help drive innovation in the healthcare industry and contribute Chinese wisdom and solutions to global ...

Becton, Dickinson and Co. (BD) is a prominent global medical technology company that specializes in advancing healthcare through innovative solutions in diagnostics, medical discovery, and care ...

Shares are modestly undervalued. BD Medical was a top-performing segment in the quarter, with the currency-neutral growth of 12%. While pharma systems business still saw some lingering effects of ...

Becton Dickinson and Co Michael Garrison; Executive Vice President, President - Medical Segment; Becton Dickinson and Co Hello, and welcome to BD's fourth-quarter and full year fiscal 2024 ...

Becton Dickinson (BDX) Company Description: Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies ...